Detail page

Knowledge Web

Person

Job Harenberg (1950-)

Internist

Name	Job Harenberg
Time	1950- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	apl. Prof. Dr. med.
Profession	Internist (characteristic profession) Arzt
Variant	J. Harenberg
Related	Universität Heidelberg. Medizinische Fakultät Mannheim (seit 05/1986) Institut für Klinische Pharmakologie (Mannheim) (zuletzt stv. Direktor) (bis 04/2015) Universitätsklinikum Mannheim (I. Medizinische Klinik) (1988-) Ludolf-Krehl-Klinik (1975-1986)
Further information	1975 Promotion an der Medizinischen Fakultät Mannheim der Universität Heidelberg; 1984 Habilitation an der Medizinischen Fakultät Heidelberg, Professor für Innere Medizin und wissenschaftlicher Mitarbeiter im Institut für Experimentelle und Klinische Pharmakologie und Toxikologie der Medizinischen Fakultät Mannheim der Universität Heidelberg; seit April 2015 im Ruhestand
Source	LCAuth https://www.linkedin.com/in/job-harenberg-md-b0422ba2/?originalSubdomain=de (Stand: 13.04.2022)
Record type	Person
GND-Identifier	108825507
Record ID	108825507
Involved in show all Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study Acquired Autoimmune Hemophilia Following SARS-CoV-2 Vaccines: Dual-Drug Effects on Blood Coagulation and the Scylla and Charybdis Phenomenon The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)? Accuracy of a rapid diagnostic test for the presence of direct oral factor Xa or thrombin inhibitors in urine - a multicenter trial Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial A fluorescent probe assay (Heparin Red) for direct detection of heparins in human plasma Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study Chromogenic assays for measurement of rivaroxaban from EDTA anticoagulated plasma samples Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI Patients' Serum and Urine as Easily Accessible Samples for the Measurement of Non–Vitamin K Antagonist Oral Anticoagulants Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference Arterial and Venous Thrombosis following Trauma and Major Orthopedic Surgery: Molecular Mechanisms and Strategies for Intervention The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation Anticoagulation in patients with impaired renal function and with haemodialysis : Anticoagulant effects, efficacy, safety, therapeutic options Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions: A Short History of Symposia Held at Villa Vigoni Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate Determination of Direct Oral Anticoagulants from Human Serum Samples Development of a Tool to Identify Patients' Preference for Vitamin K Antagonist or Direct Oral Anticoagulant Therapy Novel Methods for Assessing Oral Direct Factor Xa and Thrombin Inhibitors: Use of Point-of-Care Testing and Urine Samples A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next? Determination of Rivaroxaban in Human Plasma Samples Determination of Dabigatran in Human Plasma Samples Antikoagulation im Alter Heparin and its derivatives - Present and future Biological Profile of the Hyper/Oversulfated Chondroitin Sulfate Contaminant Isolated from Recalled Heparin Neue Antikoagulanzien und ihre Anwendungen in Klinik und Praxis : mit den neuesten internationalen Empfehlungen Vorhofflimmern und Thromboembolieprophylaxe bei älteren Patienten Comparison of Two Different Ecarin Clotting Time Methods Heparine, Thrombin- und Faktor-Xa-Inhibitoren Lepirudin bei heparininduzierter Thrombozytopenie : Grundlagen und aktueller Erkenntnisstand zur klinischen Anwendung Prophylaxe und Therapie der tiefen Beinvenenthrombose mit Ximelagatran Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis Thrombose und Antikoagulation : 37 Tabellen Effect of Thrombin Inhibitors and a Glycoprotein IIb/IIIa Receptor Antagonist in an Ex Vivo Human Experimental Thrombosis Model Reduction in Thrombus Extension and Clinical End Points in Patients after Initial Treatment for Deep Vein Thrombosis with the Fixed-Dose Body Weight-Independent Low Molecular Weight Heparin Certoparin Effects of a Heparin-Binding Protein on Blood Coagulation and Platelet Function Ist eine Adjustierung an das Körpergewicht für niedermolekulares Heparin zur Therapie der TVT erforderlich? Langzeitantikoagulation bei Patienten mit Leberzirrhose und Implantation eines transjugulären, intrahepatischen portosystemischen Shunts A fatal complication in a patient with heparin-induced thrombocytopenia type II re-exposed to heparin The Effect of Self-Monitoring the INR on Quality of Anticoagulation and Quality of Life Dimensions of Quality of Life and Self-Monitoring Therapy with Oral Anticoagulants-Still Research or Everyday Practice? Immunantwort auf rekombinantes Hirudin : Eine Übersicht Messung von Heparin-induzierten IgG-Antikörpern mittels »Fluorescence-Linked Immunofiltration Assay« (FLIFA) bei Heparin-induzierter Thrombozytopenie Typ II New trends in haemostasis : coagulation proteins, endothelium, and tissue factors New Trends in Haemostasis : Coagulation Proteins, Endothelium, and Tissue Factors Medikamentöse Beeinflussung der Fibrinbildung Zur Abspaltung und Nachweisbarkeit von Peptiden aus Fibrinogen : Ergebnisse klinischer und experimenteller Untersuchungen Experimental production of diseases Pt. 5. Liver

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Job Harenberg (1950-)

Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper

COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation

Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study

Acquired Autoimmune Hemophilia Following SARS-CoV-2 Vaccines: Dual-Drug Effects on Blood Coagulation and the Scylla and Charybdis Phenomenon

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis

The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism

Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?

Accuracy of a rapid diagnostic test for the presence of direct oral factor Xa or thrombin inhibitors in urine - a multicenter trial

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial

A fluorescent probe assay (Heparin Red) for direct detection of heparins in human plasma

Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study

A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study

Chromogenic assays for measurement of rivaroxaban from EDTA anticoagulated plasma samples

Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI

Patients' Serum and Urine as Easily Accessible Samples for the Measurement of Non–Vitamin K Antagonist Oral Anticoagulants

Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference

Arterial and Venous Thrombosis following Trauma and Major Orthopedic Surgery: Molecular Mechanisms and Strategies for Intervention

The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation

Anticoagulation in patients with impaired renal function and with haemodialysis : Anticoagulant effects, efficacy, safety, therapeutic options

Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods

Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions: A Short History of Symposia Held at Villa Vigoni

Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate

Determination of Direct Oral Anticoagulants from Human Serum Samples

Development of a Tool to Identify Patients' Preference for Vitamin K Antagonist or Direct Oral Anticoagulant Therapy

Novel Methods for Assessing Oral Direct Factor Xa and Thrombin Inhibitors: Use of Point-of-Care Testing and Urine Samples

A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study

Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery

Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next?

Determination of Rivaroxaban in Human Plasma Samples

Determination of Dabigatran in Human Plasma Samples

Antikoagulation im Alter

Heparin and its derivatives - Present and future

Biological Profile of the Hyper/Oversulfated Chondroitin Sulfate Contaminant Isolated from Recalled Heparin

Neue Antikoagulanzien und ihre Anwendungen in Klinik und Praxis : mit den neuesten internationalen Empfehlungen

Vorhofflimmern und Thromboembolieprophylaxe bei älteren Patienten

Comparison of Two Different Ecarin Clotting Time Methods

Heparine, Thrombin- und Faktor-Xa-Inhibitoren

Lepirudin bei heparininduzierter Thrombozytopenie : Grundlagen und aktueller Erkenntnisstand zur klinischen Anwendung

Prophylaxe und Therapie der tiefen Beinvenenthrombose mit Ximelagatran

Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis

Thrombose und Antikoagulation : 37 Tabellen

Effect of Thrombin Inhibitors and a Glycoprotein IIb/IIIa Receptor Antagonist in an Ex Vivo Human Experimental Thrombosis Model

Reduction in Thrombus Extension and Clinical End Points in Patients after Initial Treatment for Deep Vein Thrombosis with the Fixed-Dose Body Weight-Independent Low Molecular Weight Heparin Certoparin

Effects of a Heparin-Binding Protein on Blood Coagulation and Platelet Function

Ist eine Adjustierung an das Körpergewicht für niedermolekulares Heparin zur Therapie der TVT erforderlich?

Langzeitantikoagulation bei Patienten mit Leberzirrhose und Implantation eines transjugulären, intrahepatischen portosystemischen Shunts

A fatal complication in a patient with heparin-induced thrombocytopenia type II re-exposed to heparin

The Effect of Self-Monitoring the INR on Quality of Anticoagulation and Quality of Life

Dimensions of Quality of Life and Self-Monitoring Therapy with Oral Anticoagulants-Still Research or Everyday Practice?

Immunantwort auf rekombinantes Hirudin : Eine Übersicht

Messung von Heparin-induzierten IgG-Antikörpern mittels »Fluorescence-Linked Immunofiltration Assay« (FLIFA) bei Heparin-induzierter Thrombozytopenie Typ II

New trends in haemostasis : coagulation proteins, endothelium, and tissue factors

New Trends in Haemostasis : Coagulation Proteins, Endothelium, and Tissue Factors

Medikamentöse Beeinflussung der Fibrinbildung

Zur Abspaltung und Nachweisbarkeit von Peptiden aus Fibrinogen : Ergebnisse klinischer und experimenteller Untersuchungen

Experimental production of diseases